The SARS-CoV-2 coronavirus, the etiologic agent responsible for COVID-19 coronavirus disease, is a global threat. To better understand viral tropism, we assessed the RNA expression of the coronavirus receptor, ACE2, as well as the viral S protein priming protease TMPRSS2 thought to govern viral entry in single-cell RNA-sequencing (scRNAseq) datasets from healthy individuals generated by the Human Cell Atlas consortium.
Introduction
In December 2019, a cluster of atypical pneumonia associated with a novel coronavirus was detected in Wuhan, China 1 . This coronavirus disease, termed COVID-19, was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously termed 2019-nCoV) 2 . The virus has since spread worldwide, emerging as a serious global health concern in early 2020 3, 4 . Human-to-human transmission of the virus has been reported in several instances [5] [6] [7] and is thought to have occurred since mid-December 2019 8 . As of early March 2020, there were more than 100,000 confirmed COVID-19 cases 4 .
Patients with suspected COVID-19 have been treated in the Wuhan Jin Yintan Hospital since Dec 31st, 2019 9 . In a meta-analysis of 50,466 hospitalized patients with COVID-19 from 10 studies, most patients were from China and the average age in the included studies ranged from 41 to 56 years old 10 . The prevalence rates of fever, cough, and muscle soreness or fatigue were 89.1%, 72.2%, and 42.5%. Critical illness requiring admission to an intensive care unit occurred in 18.1% of patients, and 14.8% developed acute respiratory distress syndrome (ARDS) 10 . Acute renal injury and septic shock have been observed in 4% and 5% of patients hospitalized with COVID-19, respectively 1,9 . Chest imaging demonstrated bilateral pneumonia involvement in more than 80% of cases 1, 9, 11 . Ground-glass opacities were the most common radiologic finding on chest computed tomography (CT) 11, 12 . Abnormalities on CT were also observed preceding symptom onset in patients exposed to infected individuals, with an incidence of 93% 10, 11 .
Pathological evaluation of a patient who died of severe disease revealed diffuse alveolar damage consistent with ARDS 13 . Currently, the estimated mortality rate is 3.4% 14 . These clinical data underscore the severity of this infection. The involvement of both lungs in most of the cases suggests viral dissemination after initial infection. Viral RNA was detected in the upper airways from symptomatic patients, with higher viral loads observed in nasal swabs compared to those obtained from the throat 15 . Similar viral loads were observed in an asymptomatic patient 15 , indicating that the nasal epithelium is an important portal for initial infection, and may serve as a key reservoir for viral spread across the respiratory mucosa and an important locus mediating viral transmission. Identification of the cells hosting viral entry and permitting viral replication as well as those contributing to inflammation and disease pathology is essential to improve diagnostic and therapeutic interventions.
Cellular entry of coronaviruses depends on the binding of the spike (S) protein to a specific cellular receptor and subsequent S protein priming by cellular proteases. Similar to severe acute respiratory syndrome-associated coronavirus (SARS-CoV) 16, 17 , the SARS-CoV-2 employs angiotensin-converting enzyme-2 (ACE2) as a receptor for cellular entry.
In addition, studies have shown that the serine protease TMPRSS2 can prime S protein 15, 18 although other proteases like cathepsin B/L can also be involved 18 . For SARS, the binding affinity between the S protein and the ACE2 receptor was found to be a major determinant of viral replication rates and disease severity 19 . The SARS-CoV-2 has been shown to infect and replicate in Vero cells, a Cercopithecus aethiops (old world monkey) kidney epithelial cell line, and huh7 cells, a human hepatocarcinoma cell line 15 .
The BHK21 cell line has been shown to facilitate viral entry by the SARS-CoV-2 S protein only when engineered to express the ACE2 receptor ectopically 18 . In addition, viral entry was found to depend on TMPRSS2 activity, although cathepsin B/L activity might substitute for the loss of TMPRSS2 18 . The in vivo expression of ACE2 and TMPRSS2 (as well as other candidate proteases) by cells of the upper and lower airways and alveoli must be defined.
Previously, gene expression of ACE2 and TMPRSS2 has been reported to occur largely in type-2 alveolar (AT-2) epithelial cells 15 , which are central to SARS-CoV pathogenesis.
A study reported that ACE2 expression is absent from the upper airways 20 . The rapid spread of the SARS-CoV-2 suggests efficient human-to-human transmission which would, in turn, seem to supersede the odds of dependency on alveolar epithelial cells as the primary point of entry and viral replication 8, 21, 22 . Indeed, protein expression, based on immunohistochemistry, of ACE2 and TMPRSS2 has been reported in both nasal and bronchial epithelium 23 . To clarify the expression patterns of ACE2 and TMPRSS2 and analyze the expression of the other potential genes associated with SARS-CoV-2 pathogens at cellular resolution, we interrogated single-cell transcriptome expression data from published scRNA-seq datasets from healthy donors generated by the Human Cell Atlas consortium 24 .
Results

ACE2 and TMPRSS2 are enriched in nasal tissues and enterocytes
We investigated the gene expression of ACE2 in multiple scRNA-seq datasets from different tissues, including those of the respiratory tree 25 , ileum 26 , colon 27 , liver 28 , placenta/decidua 29 , kidney 30 , testis 31 , pancreas 32 , and prostate gland 33 . While scRNA-seq is a comprehensive assay, we note that some studies may still miss specific cell types, due to either their rarity, challenges associated with their isolation, or analysis methodology that was used. Thus, while positive (presence) results are highly reliable, absence should be interpreted with care.
The expression of ACE2, in general, is relatively low in all of the datasets analyzed.
Consistent with independent analyses 34 , we found that ACE2 is expressed in lung, airways, ileum, colon, and kidney ( Fig. 1a ; first column). It is worth noting that TMPRSS2, the primary protease important for viral entry, is highly expressed with a broader distribution ( Fig. 1a ; second column), suggesting that ACE2, rather than TMPRSS2, may be a limiting factor for viral entry at the initial stage of infection. When taking into account the expression of both genes, the cells found in mucosal epithelia in the respiratory tree, ileum, and colon are ACE2 + ( Fig. 1a ; third column), consistent with viral transmission by respiratory droplets, and the potential of fecal-oral transmission 35 . We also assessed ACE2 and TMPRSS2 expression in developmental datasets from fetal liver, fetal thymus, fetal skin, fetal bone marrow and fetal yolk sac 36, 37 and found little to no expression of ACE2 with no co-expression with TMPRSS2 (data not shown) even if single ACE2 expression is noticeable in certain cell types in placenta/decidua ( Fig. 1a ). While we cannot rule out the possibility that the virus uses alternative proteases for entry in such contexts, or that lung fetal tissue expresses the relevant genes, these results are at least consistent with early reports that fail to detect evidence of intrauterine infection through vertical transmission in women who develop COVID-19 pneumonia in late pregnancy 38 .
If future epidemiologic data are consistent with a lack vertical viral transmission, these findings may form the basis of an explanatory model for the clinical finding. However, if future evidence for vertical transmission emerges, additional scRNA-seq data can be collected and further scrutinized for the presence of rare co-expressers or alternative receptors or proteases.
Nasal goblet and ciliated cells display the highest expression of ACE2 within the larger population of respiratory epithelial cells
To further characterize specific epithelial cell types expressing ACE2, we evaluated the expression of ACE2 within lung/airway epithelia from a previous study 25 . We found that, despite a low level of expression overall, ACE2 is expressed in multiple epithelial cell types across the airway, as well as in AT-2 cells in the parenchyma, consistent with previous studies 20, 39 . Importantly, nasal epithelial cells, including previously described two clusters of goblet cells and one cluster of ciliated cells, have the highest expression among all investigated cells in the respiratory tree ( Fig. 1b ; left panel). We confirmed enriched ACE2 expression in nasal epithelial cells from a second scRNA-seq study, which, in addition to nasal brushing samples seen in the earlier dataset, included nasal biopsies 40 . The results were consistent: we found the highest expression of ACE2 in nasal secretory cells (equivalent to the two goblet cell clusters in the previous dataset) and ciliated cells ( Fig. 1b ; right panel).
In addition, scRNA-seq data from an in vitro 3D epithelial regeneration system from nasal epithelial cells 41 corroborated the expression of ACE2 in goblet/secretory cells and ciliated cells in these air-liquid interface (ALI) cultures (Extended Data Fig. 1 ). Of note, the differentiating cells in ALI acquire progressively more ACE2 and, unlike their corresponding progenitors, they have large luminal surfaces in the mature differentiated epithelium where viral entry is likely to occur (Extended Data Fig. 1 ). These results also suggest that such in vitro culture system is biologically relevant to the study of viral pathogenesis.
We also investigated the expression of known proteases associated with the entry of SARS-CoV and SARS-CoV-2. TMPRSS2, which was shown to be important for SARS-CoV/SARS-CoV-2 viral entry and SARS-CoV transmission, [16] [17] [18] is expressed in a subset of ACE2 + cells (Extended Data Fig. 2 ), suggesting that the virus might use alternative pathways for entry. In fact, it was previously shown that SARS-CoV-2 could enter TMPRSS2cells using cathepsin B/L 18 . Indeed, we found that they are much more promiscuously expressed than TMPRSS2, especially cathepsin B, which is expressed in more than 70%-90% of ACE2 + cells (Extended Data Fig. 2 ). However, whether cathepsin B/L can functionally replace TMPRSS2 has not been empirically determined. In the case of SARS-CoV, TMPRSS2 activity is documented to be important for viral transmission 42, 43 .
Respiratory expression of viral receptor/entry-associated genes and implications for viral transmissivity
We next asked whether the enriched expression of viral receptors and entry-associated 49 , with the skewed expression towards lower airway/lung parenchyma ( Fig.   2a ). Therefore, our data highlight the possibility that viral transmissivity is dependent on receptor accessibility based on spatial distribution along the respiratory tract.
Expression of genes associated with ACE2 expression: innate immunity and carbohydrate metabolism
To gain more insight into the expression patterns of genes associated with ACE2, we performed Spearman correlation analysis with Benjamini-Hochberg-adjusted p-values on genes associated with ACE2 across all cells within the lung epithelial cell dataset 25 . While the correlation coefficients are relatively low (< 0.11), likely due to low expression of ACE2, the expression pattern of the top 50 ACE2-correlated genes (all with adjusted pvalue close to 0; ranked by correlation coefficients) across the respiratory tree is similar to that of ACE2, with a skewed expression toward upper airway (Fig. 2b) . To our surprise, while some of the genes are associated with carbohydrate metabolism (possibly due to the role of goblet cells in mucin synthesis), a number of genes associated with immune functions including innate and antiviral immune functions, are over-represented in the rank list, including IDO1, IRAK3, NOS2, TNFSF10, OAS1, and MX1 ( Fig. 2b and Supplementary Table 1 ). These genes have the highest expression in nasal goblet 2 cells ( Fig. 2b) , consistent with the phenotype previously described 25 . Nonetheless, nasal goblet 1 and nasal ciliated 2 cells also significantly express these genes, but less so elsewhere ( Fig. 2b) . Given their environmental exposure and the high expression of receptor/receptor-associated enzymes ( Fig. 2a) , it is plausible that the nasal epithelial cells were conditioned and primed to express these immune-associated genes to prevent viral susceptibility. This association with innate immune pathways not only highlights the importance of host-microbe dynamics in nasal epithelia, but it may also have implications for subsequent viral pathogenesis and immune-associated protection/pathology.
Discussion
In this study, we explored multiple scRNA-seq datasets generated within the HCA consortium, and found that SARS-CoV-2 entry receptor ACE2 is more highly expressed (and co-expressed with viral entry-associated protease TMPRSS2) in nasal epithelial cells, specifically goblet and ciliated cells. This finding implicates these cells as loci of original infection and possible reservoirs for dissemination within a given patient and from person to person. Importantly, viral infection itself could drastically change the gene expression landscape in the nose and other tissues later on.
The up-regulation of innate immune genes, in association with ACE2, in highly-exposed nasal epithelial cells could be the result of their responsiveness to persistent environmental challenges, including viral infection. It would be of great interest to further investigate how other genetic, demographic, and environmental factors might affect this poised state in these cells and whether such state could influence the susceptibility to infection due to its association with viral receptor expression. Future meta-analysis of HCA data can help further assess some of these aspects.
All in all, our findings may have significant implications for understanding viral transmissivity, considering that the primary viral transmission is through respiratory droplets. Moreover, as SARS-CoV-2 is an enveloped virus, its release does not require cell lysis. Thus, the virus might exploit existing secretory pathways in nasal goblet cells for low-level, continuous-release at the early stage with no overt pathology. These discoveries could have clinical implications with respect to targeting nasal epithelial cells, especially nasal goblet cells, beyond the current usage of face masks, providing a candidate clinical option for transmission prevention and/or early-stage intervention.
Finally, it is worth highlighting that this is the first collaborative effort by a Human Cell Atlas Biological Network (the Lung), and illustrates the opportunities from integrative analyses of Human Cell Atlas data, with future examples of consortium work expected soon.
Methods
The datasets were retrieved from existing sources based on previously published data as specifically specified in the reference. We retained the cell clustering when available or reprocessed using scanpy 50 and harmony 51 , and annotated the clusters with marker genes and cell type nomenclature based on the respective studies. Illustration of the results was generated using scanpy 50 and Seurat 52 . 
